Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signaling pathway and molecular subgroups of medulloblastoma.

International journal of clinical and experimental pathology - 1 Jan 2013

Li Kay Ka-Wai, Lau Kin-Mang, Ng Ho-Keung

Abstract excerpt

Medulloblastoma (MB) is the most common malignant brain tumor in children. Although multimodality treatment regimens including surgery, radiotherapy and chemotherapy have greatly improved disease outcome, about one-third of MB patient remains incurable, and many long-term survivors are suffered f...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cerebellar Neoplasms
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Medulloblastoma

Share to Molecular Targeted Therapy

Share to Patient Selection

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 23826403
PMCID: PMC3693187

Genes

SHH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23826403-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signaling pathway and molecular subgroups of medulloblastoma.PMID 23826403Read ↗

Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.Semantic proximity Read ↗

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma TreatmentSemantic proximity Read ↗

Molecular subgroups of medulloblastoma: the current consensusSemantic proximity Read ↗

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read ↗

New Approaches in Targeted Therapy for Medulloblastoma in ChildrenSemantic proximity Read ↗

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.Semantic proximity Read ↗

Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomasSemantic proximity Read ↗

Medulloblastoma in the age of molecular subgroups: a reviewSemantic proximity Read ↗

Medulloblastoma genomics in the modern molecular eraSemantic proximity Read ↗

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read ↗

Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroupsSemantic proximity Read ↗

The molecular classification of medulloblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.